✦ LIBER ✦

Botulinum toxin therapy in hemifacial spasm: Clinical and electrophysiologic studies

✍ Scribed by Bruce D. Geller; Dr. Mark Hallett; John Ravits

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 562 KB
Volume: 12
Category: Article
ISSN: 0148-639X
DOI: 10.1002/mus.880120904

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Botulinum toxin in the treatment of blep

Botulinum toxin in the treatment of blepharospasm and hemifacial spasm

✍ C. Kenney; J. Jankovic 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 74 KB

Hemifacial spasm non-motor and motor-rel

Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy

✍ Monika Rudzińska; Magdalena Wójcik; Andrzej Szczudlik 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 180 KB

Botulinum A toxin injection in patients

Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm

✍ A. Berardelli; A. Carta; F. Stocchi; A. Formica; A. Agnoli; M. Manfredi 📂 Article 📅 1990 🏛 Springer Milan 🌐 English ⚖ 357 KB

No clinical or neurophysiological eviden

No clinical or neurophysiological evidence of botulinum toxin diffusion to non-injected muscles in patients with hemifacial spasm

✍ C. Lorenzano; S. Bagnato; F. Gilio; G. Fabbrini; A. Berardelli 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 1008 KB

Botulinum toxin treatment in patients wi

Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group

✍ A. Berardelli; A. Formica; B. Mercuri; G. Abbruzzese; A. Agnoli; R. Agostino; T. 📂 Article 📅 1993 🏛 Springer Milan 🌐 English ⚖ 535 KB

Botulinum toxin type B (Myobloc®) in sub

Botulinum toxin type B (Myobloc®) in subjects with hemifacial spasm: Results from an open-label, dose-escalation safety study

✍ Richard M. Trosch; Charles H. Adler; Eric J. Pappert 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract ## Ojbective Evaluate the safety of botulinum toxin type B (BoNT‐B) in subjects with hemifacial spasm (HFS). ## Methods This open‐label, sequential dose‐escalation study evaluated BoNT‐B in subjects with HFS. Eligible subjects were enrolled and received a single injection of one of f